Epidemiologist
Six-plus years across infectious disease surveillance, outbreak investigation, and epidemiologic analysis, including four-plus years as a CDC contractor supporting infectious disease surveillance and real-world evidence research. I build and manage case-based surveillance systems, clean and analyze surveillance data to detect cases and clusters, and translate the findings into guidance federal, state, and local partners can use.
- 6+
- years in infectious disease epidemiology
- 150+
- weekly case investigations managed during COVID-19 response
- 2022
- joined CDC DHQP as a surveillance and RWE contractor
- 1
- first-author publication on surveillance case definitions
Core expertise
- Surveillance data management and analysis. Database design, data cleaning, and epidemiologic analysis of large public health datasets using SAS, R, and SQL, with reproducible, regulatory-quality statistical programming.
- Public health communication and technical assistance. Scientific reports and manuscripts, publication-quality tables and figures, training, and phone-duty technical assistance to clinicians, public health officials, and the public.
- Federal research operations. IRB protocols, Data Use Agreements, CMS/ResDAC data access, and federal data governance and privacy compliance.
- Case-based surveillance and outbreak detection. Cluster and transmission-pattern identification across case, laboratory, and immunization-registry systems.
Experience
- Support case-based infectious disease surveillance and real-world evidence studies, cleaning and analyzing large surveillance and administrative datasets to identify cases, clusters, and trends.
- Design and manage databases and reproducible analytic pipelines for epidemiology projects, performing data validation and quality assurance across claims (MarketScan, CMS) and multi-platform EHR data (Truveta, PointClickCare, Premier/PHD).
- Program statistical analyses in SAS and R, including propensity score methods, survival analysis, longitudinal cohorts, and test-negative design.
- First author of a JAMDA (2024) publication validating diagnosis codes for nursing home infection surveillance; co-author of a Vaccine (2024) publication on real-world vaccine effectiveness.
- Independently manage IRB protocols, Data Use Agreements, and CMS ResDAC data access to ensure compliance with federal research and privacy requirements.
- Supported NIH/NIAID-funded COVID-19 vaccine clinical trials evaluating safety, immunogenicity, and effectiveness, including industry-sponsored Pfizer-BioNTech mRNA vaccine studies.
- Integrated clinical trial data with the Georgia immunization registry (GRITS) to evaluate vaccine uptake and real-world protection.
- Programmed SAS and R workflows for automated data quality checks and reconciliation.
- Conducted frontline COVID-19 surveillance and case investigations, managing 150+ weekly investigations to identify transmission risks and support outbreak control.
- Collected, validated, and maintained case-based surveillance data within state systems to support real-time public health decision-making.
- Provided phone-based public health guidance to cases, contacts, and clinicians, and performed contact tracing interviews.
Conducted a retrospective observational study of 2,000+ patients using real-world EHR data to identify epidemiologic risk factors and transmission patterns associated with Hepatitis C infection; presented findings at the FCEP Annual Conference (2019).
Methods & data
First author of a JAMDA (2024) publication validating COVID-19 diagnosis codes for nursing home infection surveillance.
Read the publication details